Singh Aman Dev, Upal Naina, Oberoi Simmi, Singh Namrata, Garg Archit, Kaur Avneet, Kaur Ashujot
Department of Community Medicine, GMC Patiala, India.
Department of Distance Education, Punjabi University, Patiala, India.
Indian J Community Med. 2023 May-Jun;48(3):492-496. doi: 10.4103/ijcm.ijcm_901_22. Epub 2023 May 30.
Approximately 40 years have passed since we first learned about the human immunodeficiency virus (HIV), but several people living with HIV (PLHIV) in developing countries such as India cannot avail treatments. This makes preventive measures, such as vaccinations, critical in these persons to avoid vaccine preventable diseases (VPDs). However, little is known about the willingness and perceptions of PLHIV regarding these vaccines. Therefore, we explored vaccine awareness and hesitancy, especially during the recent COVID-19 pandemic.
The primary objective was to determine the uptake of the Covid-19 vaccine and other VPD's among PLHIV and factors affecting the same in Antiretroviral therapy (ART) centers in a tertiary care hospital in North India.
This was a cross-sectional study of HIV patients who attended our Antiretroviral Therapy center (ART). Clinical data were collected using a questionnaire on general profile, disease information, knowledge, attitude, and practice (KAP) regarding vaccinations, and vaccination status for different VPDs.
RESULTS/FINDINGS: We enrolled 300 subjects and found that 82% of the patients attending our ART center were aware of vaccinations, most of whom were aware of the polio vaccine (=91, 30.33%), followed by tuberculosis (=61, 20.33%), and the majority of them were not aware of vaccines indicated in PLHIV. We also found that the majority (= 240, 80.23%) of patients had vaccine hesitancy, especially regarding the new COVID-19 vaccine.
There is a need to create awareness among people about the benefits and uses of vaccination to achieve the greater goal of reduced morbidity and mortality among PLHIV. There is a need for free vaccination programs for VPDs in PLHIV patients.
自我们首次了解人类免疫缺陷病毒(HIV)以来,大约已经过去了40年,但在印度等发展中国家,仍有一些艾滋病毒感染者(PLHIV)无法获得治疗。这使得诸如疫苗接种等预防措施对于这些人避免疫苗可预防疾病(VPD)至关重要。然而,对于艾滋病毒感染者对这些疫苗的意愿和看法知之甚少。因此,我们探讨了疫苗知晓率和犹豫态度,特别是在最近的新冠疫情期间。
主要目的是确定印度北部一家三级护理医院抗逆转录病毒治疗(ART)中心的艾滋病毒感染者中新冠疫苗和其他疫苗可预防疾病疫苗的接种情况以及影响接种的因素。
这是一项对到我们抗逆转录病毒治疗中心(ART)就诊的艾滋病毒患者的横断面研究。通过一份关于一般情况、疾病信息、疫苗接种知识、态度和行为(KAP)以及不同疫苗可预防疾病疫苗接种状况的问卷收集临床数据。
结果/发现:我们纳入了300名受试者,发现到我们ART中心就诊的患者中有82%知晓疫苗接种,其中大多数人知晓脊髓灰质炎疫苗(=91人,30.33%),其次是结核病疫苗(=61人,20.33%),而且他们中的大多数人不知道艾滋病毒感染者适用的疫苗。我们还发现,大多数患者(=240人,80.23%)对疫苗接种存在犹豫态度,尤其是对新的新冠疫苗。
有必要提高人们对疫苗接种益处和用途的认识,以实现降低艾滋病毒感染者发病率和死亡率这一更大目标。有必要为艾滋病毒感染者提供免费的疫苗可预防疾病疫苗接种项目。